---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-001188"
form_type: "8-K"
ticker: "AXIM"
cik: "0001514946"
company_name: "AXIM BIOTECHNOLOGIES, INC."
filed_at: "2023-05-25T23:59:59+00:00"
generated_at: "2026-06-14T14:28:22.375754+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AXIM Biotechnologies appoints Kurt Phinney as COO; grants option for 2M shares

## Summary
- Kurt Phinney appointed COO effective May 23, 2023; minimum six-month term.
- Compensation: option to buy up to 2,000,000 shares (S-8), vesting 1/6 every 30 days.
- Phinney's prior roles include VP Ops at Lumos Diagnostics and Versea Health.
- Consulting agreement with Accalle, LLC (Phinney's entity); no cash salary.
- Agreement may be terminated after initial term with 30 days' notice.

## SEC filing metadata
- accession: 0001096906-23-001188
- form_type: 8-K
- ticker: AXIM
- cik: 0001514946
- company_name: AXIM BIOTECHNOLOGIES, INC.
- filed_at: 2023-05-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/0001096906-23-001188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/axim-20230523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-001188
- JSON: https://secwatch.observer/filing/0001096906-23-001188.json
- Plain text: https://secwatch.observer/filing/0001096906-23-001188.txt

## Key facts
- Executive change
  Kurt Phinney was appointed as Chief Operating Officer at AXIM BIOTECHNOLOGIES, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On May 23, 2023, our Chief Executive Officer appointed Kurt Phinney as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/0001096906-23-001188-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.